On April 26, 2024, the launch ceremony of the "Financial Gathering Room" and the biopharmaceutical health industry finance docking meeting of Henan Academy of Medical Sciences at Zhengzhou Airport were held as scheduled. Yang Yinke, Chief Medical Officer of Henan Zhimei Biotechnology Co., Ltd., and Jin Jianxin, Deputy General Manager, were invited to lead the team and give a roadshow on the "Research and Development Project of Innovative Drug BTK Inhibitor TM471-1", which attracted the attention of the attending representatives and experts and was favored by multiple investment institutions.

       Zhengzhou Airport Zone is a national level economic pilot zone established with the approval of the State Council. It is an important engine and modern industrial base leading the development of the Central Plains economy. The Henan Academy of Medical Sciences is a comprehensive medical research and development institution organized by the Henan Provincial Government. It is integrated with the Central Plains Medical Science City and is a new type of research and development institution and public platform that integrates medical, educational, research, production, and capital in an innovative and open manner. In order to enhance the development of new quality productivity in Henan, especially in accordance with Premier Li Qiang's government work report at this year's Two Sessions, which pointed out the need to accelerate the development of innovative industries such as pharmaceuticals and actively create new growth engines such as biomanufacturing, the Zhengzhou Airport Economic Comprehensive Experimental Zone Management Committee hosted the event, and the Zhengzhou Airport Economic Comprehensive Experimental Zone Finance and Financial Bureau, Zhongyuan Medical Science City Management Committee and other units organized it. Multiple units co organized the launch ceremony of the Zhengzhou Airport "Financial Gathering Room" and the biopharmaceutical health industry finance docking meeting. The theme of the conference is "Empowering Industry and Finance, New Quality Port Area", with the aim of building bridges and paving the way, promoting the integration of industry and financing, and continuously deepening the integration of biopharmaceutical and health industry and finance in the port area. The biopharmaceutical industry is internationally recognized as a sunrise industry, but in recent years it has shown a trend of temporary cooling off and rising against the trend. Dr. Yang Yinke, Chief Medical Officer of EMICRO Biomedicine Company, was one of the ten invited roadshow guests at the conference. His roadshow was the finale, the most effective one, and the only "original anti liquid tumor industry project with core technology" in the conference roadshow content. The project has aroused strong interest from many entrepreneurs, experts, especially banks and investors on site, who have contacted EMICRO Company to express their intention to cooperate and negotiate related matters.